Privium Fund Management B.V.

Position in TSHA — Taysha Gene Therapies, Inc.

CIK 1795097 AMSTERDAM, P7

Position in TSHA

as of Mar 31, 2026 · filed May 5, 2026 Compact

Position Value

$813,093

-$93,857 QoQ

Shares Held

181,900

+10.3% QoQ

Ownership

0.063%

of shares outstanding

% of Portfolio

0.17%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2024

8 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Privium Fund Management B.V. holds $142,100,239 across 32 Biotechnology names. TSHA ranks #29 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARWR	Arrowhead Pharmaceuticals, Inc.	366,936	$23,006,887
2	IONS	Ionis Pharmaceuticals Inc	290,024	$21,777,902
3	AXSM	Axsome Therapeutics, Inc.	58,729	$9,926,375
4	PRQR	ProQR Therapeutics N.V.	5,467,149	$8,856,781
5	QURE	uniQure N.V.	486,520	$7,954,602
6	RARE	Ultragenyx Pharmaceutical Inc.	364,802	$7,642,601
7	ARQT	Arcutis Biotherapeutics, Inc.	320,972	$7,562,100
8	BMRN	Biomarin Pharmaceutical Inc	92,305	$5,214,309

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$813,093	181,900	+10.3%	Shares	Sole	2026-05-05
2025-12-31	$906,950	164,900	+22.2%	Shares	Sole	2026-02-03
2025-09-30	$441,123	134,900	0.0%	Shares	Sole	2025-11-04
2025-06-30	$311,619	134,900	0.0%	Shares	Sole	2025-07-30
2025-03-31	$187,511	134,900	0.0%	Shares	Sole	2025-05-09
2024-12-31	$233,377	134,900	+12.4%	Shares	Sole	2025-02-11
2024-09-30	$241,200	120,000	+21.8%	Shares	Sole	2024-11-01
2024-06-30	$220,640	98,500	—	Shares	Sole	2024-08-01
No filing history on record for this holder in this stock.